- Home
-
Learn, develop, connect
-
Membership
Become part of RQA today
RQA membership is a great way to connect with your QA colleagues.
More information
RQA Community Hub
Join the community - networking, discussion and more. Open to all.
More information -
Knowledge Hub
Contribute to Quasar Magazine
Could you write an interesting article for the RQA community?
More information -
About us
News Archive
WHO -Understanding our social interactions to improve influenza pandemic preparedness and response
15th February 2023The WHO Regional Office for the Western Pacific has taken steps to explore the role and potential of dark social communication for promoting health messages and reducing the spread of misleading information during and between influenza pandemics.
Swissmedic - Validity of GMP certificates during the COVID-19 pandemic
8th February 2023Update of the validity period of EMA GMP certificates
EMA - CTIS newsflash released 27th Jan 2023
2nd February 2023EMA - CTIS newsflash released
EMA - Joint statement by Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) on shortages of antibiotic medicines
2nd February 2023EMA, the European Commission and the Heads of Medicines Agencies (HMA), through the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), are closely monitoring and responding to current shortages of antibiotics affecting the EU. Shortages of medicines have been an ongoing public health concern and the situation in the EU has been exacerbated by geopolitical events or trends such as the war in Ukraine, the energy crisis and high inflation rates.
EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 January 2023
2nd February 2023EMA - Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 23-26 January 2023
EMA - Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 17-18 January 2023
2nd February 2023EMA - Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 17-18 January 2023
EMA - Use of Clinical Trials Information System becomes mandatory for new clinical trial applications in the EU
2nd February 2023Use of CTIS becomes mandatory for new clinical trial applications in the EU
EMA - update on shortages of antibiotics in the EU
2nd February 2023EMA - update on shortages of antibiotics in the EU EMA's Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) met on Thursday to discuss the progress made and to agree on the next steps in the coordinated response to the ongoing shortages of antibiotic medicines containing amoxicillin (alone and in combination with clavulanic acid) in the EU. The MSSG is made up of representatives from EMA, the European Commission and the Heads of Medicines Agencies (HMA).
FDA - Dosage and Administration Section of Labelling for Human Prescription Drug and Biological Products — Content and Format
2nd February 2023Dosage and Administration Section of Labelling for Human Prescription Drug and Biological Products — Content and Format Open for Comment
FDA - Format and Content of a REMS Document Guidance for Industry for Comment
2nd February 2023Open for Comment
- Home
- Learn, develop, connect
- Membership
- Knowledge Hub
- About us